Fluorescence In Situ Hybridization (FISH)
The UroVysion(TM) Bladder Cancer Kit (Abbott Molecular Inc.) is designed to detect aneuploidy for chromosomes 3, 7, 17, and loss of the 9p21 locus via fluorescence in situ hybridization (FISH) in urine specimens from persons with hematuria suspected of having bladder cancer. Results from the UroVysion(TM) Kit are intended for use, in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer.
Interpretive report provided.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
3 - 10 days
- Urovysion FISH
- UroVysionTM for Bladder Cancer
- FISH for Urothelial Cancer
- Chromosome Analysis, FISH for Urothelial Cancer
Collect random urine specimen (minimum 33 mL) directly into ThinPrep UroCyte collection kit available from MLabs. Alternatively, mix fresh urine 2:1 (v:v) with Carbowax (2% polyethylene glycol in 50% ethanol) or PreservCyt preservative. Refrigerate and send within 48 hours of collection.
By ordering this test the clinician acknowledges that informed consent has been obtained from the patient as required by applicable state or federal laws and the ordering clinician has authorization from the patient permitting MLabs to report the test results to the ordering clinician. Test includes pathologist interpretation of results billed as a separate additional charge. This test is not available without interpretation.